Using epilepsy drug valproate during pregnancy was significantly associated with a 48% increased risk of attention-deficit/hyperactivity disorder (ADHD) compared with children with no valproate exposure (n = 913,302).

Using epilepsy drug valproate during pregnancy was significantly associated with a 48% increased risk of attention-deficit/hyperactivity disorder (ADHD) compared with children with no valproate exposure (n = 913,302).: http://bit.ly/2GWTfhi Read more... http://bit.ly/2AweW1M